NORGES BANK - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 182 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
NORGES BANK ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q4 2022$7,319,734
-23.3%
960,5950.0%0.00%
-33.3%
Q3 2022$9,548,314
+9.5%
960,5950.0%0.00%
+50.0%
Q2 2022$8,722,203
-21.4%
960,595
-12.2%
0.00%0.0%
Q1 2022$11,103,034
-26.2%
1,093,895
+21.3%
0.00%
-33.3%
Q4 2021$15,037,000
-61.5%
901,495
+8.2%
0.00%
-66.7%
Q3 2021$39,054,000
-22.3%
833,232
+1.1%
0.01%
-18.2%
Q2 2021$50,257,000
+11.9%
824,432
+13.1%
0.01%
+10.0%
Q1 2021$44,896,000
-0.3%
728,829
+15.1%
0.01%
-9.1%
Q4 2020$45,011,000
+109.3%
632,984
+10.5%
0.01%
+83.3%
Q3 2020$21,501,000
+441.3%
573,063
+370.4%
0.01%
+500.0%
Q2 2020$3,972,000
+12.4%
121,8170.0%0.00%0.0%
Q1 2020$3,533,000
-17.3%
121,8170.0%0.00%0.0%
Q4 2019$4,270,000
+32.6%
121,817
-18.8%
0.00%0.0%
Q3 2019$3,221,000
-60.2%
150,000
-50.0%
0.00%
-66.7%
Q2 2019$8,092,000300,0000.00%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders